Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies
This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications…